The cardiac microvasculature in hypertension, cardiac hypertrophy and diastolic heart failure

Current Vascular Pharmacology

Volumn 6, Issue 4, 2008, Pages 292-300

  Hoenig, Michel R ^a   Bianchi, Cesario ^b   Rosenzweig, Anthony ^b   Sellke, Frank W ^b  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Angiogenesis; Diabetes; Endothelial progenitor cell; Heart failure; Hypertension; Hypoxia inducible factor; Microvasculature; Neovascularization

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; COBALT; COPPER; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYPOXIA INDUCIBLE FACTOR 1; PLACEBO; SCATTER FACTOR; SMALL INTERFERING RNA; VASCULOTROPIN; VASCULOTROPIN ANTIBODY; VERAPAMIL; VASCULOTROPIN A;

AGING; ANGIOGENESIS; APOPTOSIS; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CARDIOPLEGIA; CARDIOPULMONARY BYPASS; CLINICAL TRIAL; CORONARY ARTERY BLOOD FLOW; CORONARY FLOW RESERVE; DIABETES MELLITUS; DIASTOLE; DIASTOLIC HEART FAILURE; DISEASE COURSE; DISEASE MODEL; DRUG ACTIVITY; EXERCISE; GENE THERAPY; HEART FUNCTION; HEART HYPERTROPHY; HEART INFARCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE ISCHEMIA; HEART STRESS; HEART SURGERY; HUMAN; HYPERTENSION; MICROCIRCULATION; MICROVASCULATURE; NONHUMAN; PERCUTANEOUS CORONARY INTERVENTION; REVIEW; RISK FACTOR; STEM CELL; STEM CELL MOBILIZATION; SURVIVAL; UPREGULATION; ANIMAL; CARDIOMEGALY; ENDOTHELIUM CELL; GENETICS; METABOLISM; PATHOPHYSIOLOGY;

AGING; ANIMALS; CARDIOMEGALY; CORONARY CIRCULATION; DIABETES COMPLICATIONS; ENDOTHELIAL CELLS; GENE THERAPY; HEART FAILURE, DIASTOLIC; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MICROCIRCULATION; NEOVASCULARIZATION, PHYSIOLOGIC; STEM CELLS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 55449117365     PISSN: 15701611     EISSN: None     Source Type: Journal    
DOI: 10.2174/157016108785909779     Document Type: Review

References (122)

1. Hunt SA, Baker DW, Chin MH, Cinquegrani MP, Feldman AM, Francis GS, et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. A report of the american college of cardiology/american heart association task force on practice guidelines (committee to revise the 1995 guidelines for the evaluation and management of heart failure). J Am Coll Cardiol 2001; 38: 2101-13.
2. Bhatia RS, Tu JV, Lee DS, Austin PC, Fang J, Haouzi A, et al. Outcome of heart failure with preserved ejection fraction in a population- based study. N Engl J Med 2006; 355: 260-269.
3. Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 2006; 355: 251-259.
4. Kitzman DW, Gardin JM, Gottdiener JS, Arnold A, Boineau R, Aurigemma G, et al. Importance of heart failure with preserved systolic function in patients > or = 65 years of age. CHS Research Group. Cardiovascular Health Study. Am J Cardiol 2001; 87: 413-9.
5. Redfield MM. Understanding "diastolic" heart failure. N Engl J Med 2004; 350: 1930-1931.
6. Masoudi FA, Havranek EP, Smith G, Fish RH, Steiner JF, Ordin DL, et al. Gender, age, and heart failure with preserved left ventricular systolic function. J Am Coll Cardiol 2003; 41: 217-23.
7. Yancy CW, Lopatin M, Stevenson LW, De Marco T, Fonarow GC. Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the acute decompensated heart failure national registry (ADHERE) database. J Am Coll Cardiol 2006; 47: 76-84.
8. Luchi RJ, Snow E, Luchi JM, Nelson CL, Pircher FJ. Left ventricular function in hospitalized geriatric patients. J Am Geriatr Soc 1982; 30: 700-5.
9. Betocchi S, Hess OM. LV hypertrophy and diastolic heart failure. Heart Fail Rev 2000; 5: 333-6.
10. Bonow RO, Udelson JE. Left ventricular diastolic dysfunction as a cause of congestive heart failure. Mechanisms and management. Ann Intern Med 1992; 117: 502-10.
11. Klapholz M, Maurer M, Lowe AM, Messineo F, Meisner JS, Mitchell J, et al. Hospitalization for heart failure in the presence of a normal left ventricular ejection fraction: Results of the New York heart failure registry. J Am Coll Cardiol 2004; 43: 1432-1438.
12. Kitzman DW, Daniel KR. Diastolic heart failure in the elderly. Clin Geriatr Med 2007; 23: 83-106.
13. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jr, et al. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 2003; 42: 1206-1252.
14. Gandhi SK, Powers JC, Nomeir AM, Fowle K, Kitzman DW, Rankin KM, et al. The pathogenesis of acute pulmonary edema associated with hypertension. N Engl J Med 2001; 344: 17-22.
15. Kramer K, Kirkman P, Kitzman D, Little WC. Flash pulmonary edema: association with hypertension and reoccurrence despite coronary revascularization. Am Heart J 2000; 140: 451-5.
16. Wei JY, Li Y, Lincoln T, Grossman W, Mendelowitz D. Chronic exercise training protects aged cardiac muscle against hypoxia. J Clin Invest 1989; 83: 778-84.
17. Aroesty JM, McKay RG, Heller GV, Royal HD, Als AV, Grossman W. Simultaneous assessment of left ventricular systolic and diastolic dysfunction during pacing-induced ischemia. Circulation 1985; 71: 889-900.
18. Nishimura H, Kubo S, Nishioka A, Imamura K, Kawamura K, Hasegawa M. Left ventricular diastolic function of spontaneously hypertensive rats and its relationship to structural components of the left ventricle. Clin Sci (Lond) 1985; 69: 571-9.
19. Vitullo J, Penn M, Rakusan K, Wicker P. Effects of hypertension and aging on coronary arteriolar density. Hypertension 1993; 21: 406-414.
20. Isoyama S. Hypertension and age-related changes in the heart. Implications for drug therapy. Drugs Aging 1994; 5: 102-15.
21. Wei JY. Age and the cardiovascular system. N Engl J Med 1992; 327: 1735-9.
22. Tomanek RJ, Aydelotte MR, Butters CA. Late-onset renal hypertension in old rats alters myocardial microvessels. Am J Physiol 1990; 259: H1681-7.
23. Tomanek RJ, Hovanec JM. The effects of long-term pressureoverload and aging on the myocardium. J Mol Cell Cardiol 1981; 13: 471-88.
24. Rakusan K, Wicker P. Morphometry of the small arteries and arterioles in the rat heart: effects of chronic hypertension and exercise. Cardiovasc Res 1990; 24: 278-84.
25. Rakusan K, Nagai J. Morphometry of arterioles and capillaries in hearts of senescent mice. Cardiovasc Res 1994; 28: 969-72.
26. Hachamovitch R, Wicker P, Capasso JM, Anversa P. Alterations of coronary blood flow and reserve with aging in Fischer 344 rats. Am J Physiol 1989; 256: H66-73.
27. Flanagan MF, Fujii AM, Colan SD, Flanagan RG, Lock JE. Myocardial angiogenesis and coronary perfusion in left ventricular pressure- overload hypertrophy in the young lamb. Evidence for inhibition with chronic protamine administration. Circ Res 1991; 68: 1458-70.
28. Flanagan MF, Aoyagi T, Currier JJ, Colan SD, Fujii AM. Effect of young age on coronary adaptations to left ventricular pressure overload hypertrophy in sheep. J Am Coll Cardiol 1994; 24: 1786-96.
29. Rakusan K, du Mesnil de Rochemont W, Braasch W, Tschopp H, Bing RJ. Capacity of the terminal vascular bed during normal growth, in cardiomegaly, and in cardiac atrophy. Circ Res 1967; 21: 209-15.
30. Rakusan K, Flanagan MF, Geva T, Southern J, Van Praagh R. Morphometry of human coronary capillaries during normal growth and the effect of age in left ventricular pressure-overload hypertrophy. Circulation 1992; 86: 38-46.
31. Friehs I, del Nido PJ. Increased susceptibility of hypertrophied hearts to ischemic injury. Ann Thorac Surg 2003; 75: S678-84.
32. Friehs I, Moran AM, Stamm C, Choi YH, Cowan DB, McGowan FX, et al. Promoting angiogenesis protects severely hypertrophied hearts from ischemic injury. Ann Thorac Surg 2004; 77: 2004-10; discussion 2011.
33. Yoon Y-s, Uchida S, Masuo O, Cejna M, Park J-S, Gwon H-c, et al. Progressive attenuation of myocardial vascular endothelial growth factor expression is a seminal event in diabetic cardiomyopathy: restoration of microvascular homeostasis and recovery of cardiac function in diabetic cardiomyopathy after replenishment of local vascular endothelial growth factor. Circulation 2005; 111: 2073-2085.
34. Schaffer SW, Tan BH, Wilson GL. Development of a cardiomyopathy in a model of noninsulin-dependent diabetes. Am J Physiol Heart Circ Physiol 1985; 248: H179-185.
35. Kannel WB, Hjortland M, Castelli WP. Role of diabetes in congestive heart failure: the Framingham study. Am J Cardiol 1974; 34: 29-34.
36. Frohlich ED. Risk Mechanisms in hypertensive heart disease. Hypertension 1999; 34: 782-789.
37. Slama M, Susic D, Varagic J, Frohlich ED. Diastolic dysfunction in hypertension. Curr Opin Cardiol 2002; 17: 368-73.
38. Wangler R, Peters K, Marcus M, Tomanek R. Effects of duration and severity of arterial hypertension and cardiac hypertrophy on coronary vasodilator reserve. Circ Res 1982; 51: 10-18.
39. Houghton JL, Frank MJ, Carr AA, von Dohlen TW, Prisant LM. Relations among impaired coronary flow reserve, left ventricular hypertrophy and thallium perfusion defects in hypertensive patients without obstructive coronary artery disease. J Am Coll Cardiol 1990; 15: 43-51.
40. Pringle SD, Dunn FG, Tweddel AC, Martin W, Macfarlane PW, McKillop JH, et al. Symptomatic and silent myocardial ischaemia in hypertensive patients with left ventricular hypertrophy. Br Heart J 1992; 67: 377-82.
41. Marcus ML, Doty DB, Hiratzka LF, Wright CB, Eastham CL. Decreased coronary reserve: a mechanism for angina pectoris in patients with aortic stenosis and normal coronary arteries. N Engl J Med 1982; 307: 1362-6.
42. Debl K, Djavidani B, Buchner S, Lipke C, Nitz W, Feuerbach S, et al. Delayed hyperenhancement in magnetic resonance imaging of left ventricular hypertrophy caused by aortic stenosis and hypertrophic cardiomyopathy: visualisation of focal fibrosis. Heart 2006; 92: 1447-1451.
43. La Salvia EA, Gilkeson RC, Dahms BB, Siwik E. Delayed contrast enhancement magnetic resonance imaging in congenital aortic stenosis. Pediatr Cardiol 2006; 27: 388-90.
44. Kim RJ, Fieno DS, Parrish TB, Harris K, Chen E-L, Simonetti O, et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 1999; 100: 1992-2002.
45. Brush JE, Jr., Cannon RO, 3rd, Schenke WH, Bonow RO, Leon MB, Maron BJ, et al. Angina due to coronary microvascular disease in hypertensive patients without left ventricular hypertrophy. N Engl J Med 1988; 319: 1302-7.
46. Scheler S, Motz W, Strauer BE. Mechanism of angina pectoris in patients with systemic hypertension and normal epicardial coronary arteries by arteriogram. Am J Cardiol 1994; 73: 478-82.
47. Opherk D, Mall G, Zebe H, Schwarz F, Weihe E, Manthey J, et al. Reduction of coronary reserve: a mechanism for angina pectoris in patients with arterial hypertension and normal coronary arteries. Circulation 1984; 69: 1-7.
48. de Marchi SF, Oswald P, Windecker S, Meier B, Seiler C. Reciprocal relationship between left ventricular filling pressure and the recruitable human coronary collateral circulation. Eur Heart J 2005; 26: 558-66.
49. Sano M, Minamino T, Toko H, Miyauchi H, Orimo M, Qin Y, et al. p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload. Nature 2007; 446: 444-8.
50. Simons M, Ware JA. Therapeutic angiogenesis in cardiovascular disease. Nat Rev Drug Discov 2003; 2: 863-71.
51. Rivard A, Berthou-Soulie L, Principe N, Kearney M, Curry C, Branellec D, et al. Age-dependent defect in vascular endothelial growth factor expression is associated with reduced hypoxiainducible factor 1 activity. J Biol Chem 2000; 275: 29643-7.
52. Frenkel-Denkberg G, Gershon D, Levy AP. The function of hypoxia- inducible factor 1 (HIF-1) is impaired in senescent mice. FEBS Lett 1999; 462: 341-4.
53. Catrina S-B, Okamoto K, Pereira T, Brismar K, Poellinger L. Hyperglycemia regulates hypoxia-inducible factor-1{alpha} protein stability and function. Diabetes 2004; 53: 3226-3232.
54. Marfella R, Esposito K, Nappo F, Siniscalchi M, Sasso FC, Portoghese M, et al. Expression of angiogenic factors during acute coronary syndromes in human type 2 diabetes. Diabetes 2004; 53: 2383-2391.
55. Chang EI, Loh SA, Ceradini DJ, Chang EI, Lin S-e, Bastidas N, et al. Age decreases endothelial progenitor cell recruitment through decreases in hypoxia-inducible factor 1{alpha} stabilization during ischemia. Circulation 2007; 116: 2818-29.
56. Rivard A, Fabre J-E, Silver M, Chen D, Murohara T, Kearney M, et al. Age-dependent impairment of angiogenesis. Circulation 1999; 99: 111-120.
57. Bruick RK, McKnight SL. A conserved family of prolyl-4hydroxylases that modify HIF. Science 2001; 294: 1337-40.
58. Jesmin S, Hattori Y, Togashi H, Ueno K, Yoshioka M, Sakuma I. Age-related changes in cardiac expression of VEGF and its angiogenic receptor KDR in stroke-prone spontaneously hypertensive rats. Mol Cell Biochem 2005; 272: 63-73.
59. Rivard A, Silver M, Chen D, Kearney M, Magner M, Annex B, et al. Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF. Am J Pathol 1999; 154: 355-363.
60. Lee SH, Wolf PL, Escudero R, Deutsch R, Jamieson SW. Thistlethwaite PA. Early expression of angiogenesis factors in acute myocardial ischemia and infarction. N Engl J Med 2000; 342: 626-633.
61. Marfella R, D'Amico M, Di Filippo C, Piegari E, Nappo F, Esposito K, et al. Myocardial infarction in diabetic rats: role of hyperglycaemia on infarct size and early expression of hypoxia-inducible factor 1. Diabetologia 2002; 45: 1172-81.
62. Chou E, Suzuma I, Way KJ, Opland D, Clermont AC, Naruse K, et al. Decreased cardiac expression of vascular endothelial growth factor and its receptors in insulin-resistant and diabetic states: A possible explanation for impaired collateral formation in cardiac tissue. Circulation 2002; 105: 373-379.
63. Boodhwani M, Sodha NR, Mieno S, Xu S-H, Feng J, Ramlawi B, et al. Functional, cellular, and molecular characterization of the angiogenic response to chronic myocardial ischemia in diabetes. Circulation 2007; 116: I-31-37.
64. Friehs I, Margossian RE, Moran AM, Cao-Danh H, Moses MA, del Nido PJ. Vascular endothelial growth factor delays onset of failure in pressure-overload hypertrophy through matrix metalloproteinase activation and angiogenesis. Basic Res Cardiol 2006; 101: 204-13.
65. Friehs I, Barillas R, Vasilyev NV, Roy N, McGowan FX, del Nido PJ. Vascular endothelial growth factor prevents apoptosis and preserves contractile function in hypertrophied infant heart. Circulation 2006; 114: I290-5.
66. Wang X, Hu Q, Mansoor A, Lee J, Wang Z, Lee T, et al. Bioenergetic and functional consequences of stem cell-based VEGF delivery in pressure-overloaded swine hearts. Am J Physiol Heart Circ Physiol 2006; 290: H1393-405.
67. Izumiya Y, Shiojima I, Sato K, Sawyer DB, Colucci WS, Walsh K. Vascular endothelial growth factor blockade promotes the transition from compensatory cardiac hypertrophy to failure in response to pressure overload. Hypertension 2006; 47: 887-893.
68. Shiojima I, Sato K, Izumiya Y, Schiekofer S, Ito M, Liao R, et al. Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure. J Clin Invest 2005; 115: 2108-18.
69. Giordano FJ, Gerber H-P, Williams S-P, VanBruggen N, Bunting S, Ruiz-Lozano P, et al. A cardiac myocyte vascular endothelial growth factor paracrine pathway is required to maintain cardiac function. Proc Natl Acad Sci 2001; 98: 5780-5785.
70. Shyu KG, Liou JY, Wang BW, Fang WJ, Chang H. Carvedilol prevents cardiac hypertrophy and overexpression of hypoxia-inducible factor-1alpha and vascular endothelial growth factor in pressure-overloaded rat heart. J Biomed Sci 2005; 12: 409-20.
71. Hilfiker-Kleiner D, Hilfiker A, Kaminski K, Schaefer A, Park J-K, Michel K, et al. Lack of JunD promotes pressure overload-induced apoptosis, hypertrophic growth, and angiogenesis in the heart. Circulation 2005; 112: 1470-1477.
72. Sakaguchi G, Tambara K, Sakakibara Y, Ozeki M, Yamamoto M, Premaratne G, et al. Control-released hepatocyte growth factor prevents the progression of heart failure in stroke-prone spontaneously hypertensive rats. Ann Thorac Surg 2005; 79: 1627-34.
73. Muller P, Kazakov A, Semenov A, Bohm M, Laufs U. Pressure-induced cardiac overload induces upregulation of endothelial and myocardial progenitor cells. Cardiovasc Res 2008; 77: 151-9.
74. Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, Silver M, et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 1999; 85: 221-228.
75. Zhang ZG, Zhang L, Jiang Q, Chopp M. Bone marrow-derived endothelial progenitor cells participate in cerebral neovascularization after focal cerebral ischemia in the adult mouse. Circ Res 2002; 90: 284-288.
76. Moore MA, Hattori K, Heissig B, Shieh JH, Dias S, Crystal RG, et al. Mobilization of endothelial and hematopoietic stem and progenitor cells by adenovector-mediated elevation of serum levels of SDF-1, VEGF, and angiopoietin-1. Ann N Y Acad Sci 2001; 938: 36-45; discussion 45-7.
77. Kalka C, Masuda H, Takahashi T, Gordon R, Tepper O, Gravereaux E, et al. Vascular endothelial growth factor165 gene transfer augments circulating endothelial progenitor cells in human subjects. Circ Res 2000; 86: 1198-1202.
78. Zentilin L, Tafuro S, Zacchigna S, Arsic N, Pattarini L, Sinigaglia M, et al. Bone marrow mononuclear cells are recruited to the sites of VEGF-induced neovascularization but are not incorporated into the newly formed vessels. Blood 2006; 107: 3546-3554.
79. Asahara T, Takahashi T, Masuda H, Kalka C, Chen D, Iwaguro H, et al. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J 1999; 18: 3964-72.
80. Li B, Sharpe EE, Maupin AB, Teleron AA, Pyle AL, Carmeliet P, et al. VEGF and PlGF promote adult vasculogenesis by enhancing EPC recruitment and vessel formation at the site of tumor neovascularization. FASEB J 2006; 20: 1495-1497.
81. Nagasawa T, Kikutani H, Kishimoto T. Molecular cloning and structure of a pre-B-cell growth-stimulating factor. PNAS 1994; 91: 2305-2309.
82. Yamaguchi J-i, Kusano KF, Masuo O, Kawamoto A, Silver M, Murasawa S, et al. Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation 2003; 107: 1322-1328.
83. Jo DY, Rafii S, Hamada T, Moore MA. Chemotaxis of primitive hematopoietic cells in response to stromal cell-derived factor-1. J Clin Invest 2000; 105: 101-11.
84. Jin DK, Shido K, Kopp HG, Petit I, Shmelkov SV, Young LM, et al. Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4+ hemangiocytes. Nat Med 2006; 12: 557-67.
85. Grunewald M, Avraham I, Dor Y, Bachar-Lustig E, Itin A, Jung S, et al. VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells. Cell 2006; 124: 175-89.
86. Schaefer A, Meyer GP, Fuchs M, Klein G, Kaplan M, Wollert KC, et al. Impact of intracoronary bone marrow cell transfer on diastolic function in patients after acute myocardial infarction: results from the BOOST trial. Eur Heart J 2006; 27: 929-935.
87. Zhang S, Guo J, Zhang P, Liu Y, Jia Z, Ma K, et al. Long-term effects of bone marrow mononuclear cell transplantation on left ventricular function and remodeling in rats. Life Sci 2004; 74: 2853-64.
88. Stojanovic MM, O'Brien E, Lyons S, Stanton AV. Silent myocardial ischaemia in treated hypertensives with and without left ventricular hypertrophy. Blood Press Monit 2003; 8: 45-51.
89. Otterstad JE, Davies M, Ball SG, Erikssen J, Birkin E, Virk S, et al. Left ventricular hypertrophy and myocardial ischaemia in hypertension: the THAMES Study. Eur Heart J 1993; 14: 1622-8.
90. Misao Y, Takemura G, Arai M, Ohno T, Onogi H, Takahashi T, et al. Importance of recruitment of bone marrow-derived CXCR4+ cells in post-infarct cardiac repair mediated by G-CSF. Cardiovasc Res 2006; 71: 455-65.
91. Petit I, Szyper-Kravitz M, Nagler A, Lahav M, Peled A, Habler L, et al. G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nat Immunol 2002; 3: 687-94.
92. Goldberg MA, Schneider TJ. Similarities between the oxygen-sensing mechanisms regulating the expression of vascular endothelial growth factor and erythropoietin. J Biol Chem 1994; 269: 4355-9.
93. Ceradini DJ, Kulkarni AR, Callaghan MJ, Tepper OM, Bastidas N, Kleinman ME, et al. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 2004; 10: 858-64.
94. Schioppa T, Uranchimeg B, Saccani A, Biswas SK, Doni A, Rapisarda A, et al. Regulation of the Chemokine Receptor CXCR4 by Hypoxia. J Exp Med 2003; 198: 1391-1402.
95. Zagzag D, Krishnamachary B, Yee H, Okuyama H, Chiriboga L, Ali MA, et al. Stromal Cell-derived factor-1{alpha} and CXCR4 expression in hemangioblastoma and clear cell-renal cell carcinoma: von Hippel-Lindau loss-of-function induces expression of a ligand and its receptor. Cancer Res 2005; 65: 6178-6188.
96. Mieno S, Ramlawi B, Boodhwani M, Clements RT, Minamimura K, Maki T, et al. Role of stromal-derived factor-1{alpha} in the induction of circulating CD34+CXCR4+ progenitor cells after cardiac surgery. Circulation 2006; 114: 186-192.
97. Scheubel RJ, Zorn H, Silber RE, Kuss O, Morawietz H, Holtz J, et al. Age-dependent depression in circulating endothelial progenitor cells in patients undergoing coronary artery bypass grafting. J Am Coll Cardiol 2003; 42: 2073-80.
98. Turan RG, Brehm M, Koestering M, Tobias Z, Bartsch T, Steiner S, et al. Factors influencing spontaneous mobilization of CD34(+) and CD133(+) progenitor cells after myocardial infarction. Eur J Clin Invest 2007; 37: 842-51.
99. Hachamovitch R, Wicker P, Capasso JM, Anversa P. Alterations of coronary blood flow and reserve with aging in Fischer 344 rats. Am J Physiol Heart Circ Physiol 1989; 256: H66-73.
100. Assayag P, Charlemagne D, de Leiris J, Boucher F, Valere P-E, Lortet S, et al. Senescent heart compared with pressure overload-induced hypertrophy. Hypertension 1997; 29: 15-21.
101. Frohlich ED, Apstein C, Chobanian AV, Devereux RB, Dustan HP, Dzau V, et al. The heart in hypertension. N Engl J Med 1992; 327: 998-1008.
102. Tomanek RJ, Aydelotte MR, Anderson KE, Torry RJ. Coronary blood flow in senescent rats with late-onset hypertension. Am J Physiol Heart Circ Physiol 1993; 264: H1854-1860.
103. Lakatta EG. Do hypertension and aging have a similar effect on the myocardium? Circulation 1987; 75: I69-77.
104. Fadini GP, Sartore S, Schiavon M, Albiero M, Baesso I, Cabrelle A, et al. Diabetes impairs progenitor cell mobilisation after hindlimb ischaemia-reperfusion injury in rats. Diabetologia 2006; 49: 3075-84.
105. Hill JM, Zalos G, Halcox JPJ, Schenke WH, Waclawiw MA, Quyyumi AA, et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003; 348: 593-600.
106. Loomans CJ, de Koning EJ, Staal FJ, Rookmaaker MB, Verseyden C, de Boer HC, et al. Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes. Diabetes 2004; 53: 195-9.
107. Kunz GA, Liang G, Cuculi F, Gregg D, Vata KC, Shaw LK, et al. Circulating endothelial progenitor cells predict coronary artery disease severity. Am Heart J 2006; 152: 190-5.
108. Heeschen C, Lehmann R, Honold J, Assmus B, Aicher A, Walter DH, et al. Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease 10.1161/01.CIR.0000124476.32871.E3. Circulation 2004; 109: 1615-1622.
109. Benjamin EJ, Levy D, Anderson KM, Wolf PA, Plehn JF, Evans JC, et al. Determinants of Doppler indexes of left ventricular diastolic function in normal subjects (the Framingham Heart Study). Am J Cardiol 1992; 70: 508-15.
110. Hees PS, Fleg JL, Mirza ZA, Ahmed S, Siu CO, Shapiro EP. Effects of normal aging on left ventricular lusitropic, inotropic, and chronotropic responses to dobutamine. J Am Coll Cardiol 2006; 47: 1440-7.
111. Arbab-Zadeh A, Dijk E, Prasad A, Fu Q, Torres P, Zhang R, et al. Effect of aging and physical activity on left ventricular compliance. Circulation 2004; 110: 1799-1805.
112. Tomanek RJ. Effects of age and exercise on the extent of the myocardial capillary bed. Anat Rec 1970; 167: 55-62.
113. Rakusan K, Poupa O. Capillaries and muscle fibres in the heart of old rats. Gerontologia 1964; 69: 107-12.
114. Bloor CM, Leon AS. Interaction of age and exercise on the heart and its blood supply. Lab Invest 1970; 22: 160-5.
115. Castardeli E, Duarte DR, Minicucci MF, Azevedo PS, Matsubara BB, Matsubara LS, et al. Tobacco smoke-induced left ventricular remodelling is not associated with metalloproteinase-2 or -9 activation. Eur J Heart Fail 2007; 9: 1081-5.
116. Adams V, Lenk K, Linke A, Lenz D, Erbs S, Sandri M, et al. Increase of circulating endothelial progenitor cells in patients with coronary artery disease after exercise-induced ischemia. Arterioscler Thromb Vasc Biol 2004; 24: 684-690.
117. Sarto P, Balducci E, Balconi G, Fiordaliso F, Merlo L, Tuzzato G, et al. Effects of exercise training on endothelial progenitor cells in patients with chronic heart failure. J Card Fail 2007; 13: 701-8.
118. Endoh H, Kaneko T, Nakamura H, Doi K, Takahashi E. Improved cardiac contractile functions in hypoxia-reoxygenation in rats treated with low concentration Co(2+). Am J Physiol Heart Circ Physiol 2000; 279: H2713-9.
119. Jiang Y, Reynolds C, Xiao C, Feng W, Zhou Z, Rodriguez W, et al. Dietary copper supplementation reverses hypertrophic cardiomyopathy induced by chronic pressure overload in mice. J Exp Med 2007; 204: 657-66.
120. Elsherif L, Wang L, Saari JT, Kang YJ. Regression of dietary copper restriction-induced cardiomyopathy by copper repletion in mice. J Nutr 2004; 134: 855-860.
121. Hogg K, McMurray J. The treatment of heart failure with preserved ejection fraction ("diastolic heart failure"). Heart Fail Rev 2006; 11: 141-6.
122. Susic D, Frohlich ED. Optimal treatment of hypertension with diastolic heart failure. Heart Fail Clin 2008; 4: 117-24.